# FDA Inspection 1269921 - Revance Therapeutics, Inc. - May 01, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/revance-therapeutics-inc/3536ce12-6e01-4d9f-ab95-f161973669b3/
Source feed: FDA_Inspections

> FDA Inspection 1269921 for Revance Therapeutics, Inc. on May 01, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269921
- Company Name: Revance Therapeutics, Inc.
- Inspection Date: 2025-05-01
- Product Type: Human Drugs
- Office Name: San Francisco District Office

## Related Documents

- [FDA Inspection 1269921 - 2025-05-01](https://www.globalkeysolutions.net/api/records/fda_inspections/revance-therapeutics-inc/be88cb67-1a16-4e2f-8531-a6c276fb6212/)

Company: https://www.globalkeysolutions.net/companies/revance-therapeutics-inc/33277fcf-5886-406e-8332-bc85057ba4bc

Office: https://www.globalkeysolutions.net/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df